MASTALERZ, HAROLD,WITTMAN, MARK D.,ZIMMERMANN, KURT,SAULNIER, MARK G.,VELAPARTHI, UPENDER,VYAS, DOLATRAI M.,ZHANG, GUIFEN,JOHNSON, WALTER LEWIS,FRENNESSON, DAVID B.,SANG, XIAOPENG,LIU, PEIYING,LANGLEY
申请号：
HRP20140688
公开号：
HRP20140688T1
申请日:
2014.07.17
申请国别(地区):
HR
年份:
2014
代理人:
摘要：
The invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease.
